Affordable Access

Publisher Website

Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage

Authors
Journal
Vaccine
0264-410X
Publisher
Elsevier
Publication Date
Volume
26
Issue
10
Identifiers
DOI: 10.1016/j.vaccine.2007.12.036
Keywords
  • Pneumococci
  • Serotype
  • Vaccination
  • Turkey

Abstract

Summary This paper aims to bring up the most prevalent pneumococcal serotypes and serogroups detected in recent Turkish studies. The current PCV-7 formulation covers only 37% of IPI in Turkey and if serotypes/groups 4, 6V, 9B, 18C in the current formulation are replaced with 1, 3, 6B and 9A in PCV-7, then the vaccination coverage will increase up to 64%, an improvement that is significant statistically. Similarly, if 11A, 12F, 15B, 17F and 22F are substituted with 6A, 9A, 9L, 19C and 23B in existing PPV-23, the new formulation will increase coverage up to 95% for Turkish population.

There are no comments yet on this publication. Be the first to share your thoughts.